Deregulation of glutamine PRPP amidotransferase activity
AssigneesPurdue Research Foundation, The Board of Trustees of the University of Illinois
InventorsHoward Zalkin, Janet L. Smith, Robert L. Switzer
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a modified amidotransferase. The amino acid sequence of the modified amidotransferase differs from the amino acid sequence of a native E. coli glutamine PRPP amidotransferase in that one or more amino acid residues of the modified amidotransferase are substituted at positions equivalent to amino acid positions in Bacillus amidotransferase selected from the group consisting of 282, 283, 307, and 347 of SEQ ID NO:1, wherein the modified amidotransferase is less sensitive to end-product inhibition than is the native E. coli glutamine PRPP amidotransferase.
Claims2
A modified E. coli glutamine PRPP amidotransferase wherein the amino acid sequence of said modified E. coli amidotransferase differs from the amino acid sequence of a native E. coli glutamine PRPP amidotransferase in that one or more amino acid residues of said modified amidotransferase are substituted at positions equivalent to amino acid positions in Bacillus amidotransferase selected from the group consisting of 282, 283, 307, and 347 of SEQ ID NO:
- 1 with amino acids not native to said position or positions in E. coli wherein said equivalent positions are identified based on comparison of amino acid sequences of Bacillus and E. coli glutamine PRPP amidotransferases and wherein said modified E. coli amidotransferase is less sensitive to end-product inhibition than is the native E. coli glutamine PRPP amidotransferase.
Dependencies are inferred from the claim text.